As the demand for affordable healthcare continues to rise, tension is growing between the need to increase access to high-quality care and the need to contain the growing costs of care. Government, insurance companies and commercial payers are aggressively pursuing programs to lower the escalating cost, thereby increasing financial pressure on developers, manufacturers and providers. Regulatory agencies are also seeking reform that could radically impact long-held business models while increasing pressure to provide more meaningful comparative clinical trial data.

Despite increasing pressure from government and regulatory bodies, the number of new entrants in the medical science space and the sophistication of the sales and marketing function of competitors continue to grow. IBC Group advises different stakeholders across the healthcare value chain on how to address their most pressing challenges and opportunities.

IBC Group possesses the unique ability to generate insights across physicians, thought leaders, patients, competitors, partners, regulators, suppliers, and payers. IBC Group uses its deep industry experience and analytical tools to synthesize this diverse set of insights and develop high-impact solutions. IBC Group’ Healthcare Practice advises the leading Medical Technology, Pharmaceutical, and Biotechnology companies across a range of strategic, competitive and operational issues.

IBC Group areas of expertise:

IBC Group’s services, which are tailored to meet the client’s specific needs, we conducted baseline studies in various specialties including health, health project evaluations, organizational capacity assessment of health care institutions, Business plan design for different institutions, Performance Based Financing (PBF) verification and counter verification, Policy elaboration, Law elaboration in health sector, quality assurance and International certification of institutions.